Nephrology Intensive Review 2022 thoroughly reviews modern nephrology practices. With 70+ lectures, case discussions, and board preparation seminars, Harvard Medical School’s clinical professors provide an essential resource.
The Intensive Review of Nephrology emphasizes acid-base and electrolyte problems, glomerulonephritis, transplantation, renal pathology, and clinical imaging in board review practice sessions and Q&As. Continuing medical education insights will also be provided:
- Enhancing prognosis and therapy selection with genetic testing
- Point-of-care ultrasound basics: acquisition and interpretation
- Dialysis access inspection
- Investigating SGLT2 inhibitors for renal disease treatment in diabetic and non-diabetic patients.
- Investigating crypto nephrology instances
- Explore the latest immunology and nephrology advances beyond transplant patients.
Goals of Nephrology Intensive Review 2022:
Participant skills after Nephrology Intensive Review 2022 include:
- Briefly summarize the newest clinical nephrology guidelines at Nephrology Intensive Review 2022.
- Discuss complex renal problem clinical manifestations and differential diagnosis.
- Take advantage of renal disease treatment choices.
- Analysis and interpretation of clinically relevant literature at Nephrology Intensive Review 2022.
- Explain renal disease treatment pathophysiology.
- Improve ABIM nephrology certification/recertification exam performance by combining knowledge.
TOPICS / SPEAKERS of Nephrology Intensive Review 2022:
- Renal Physiology for the Boards –Â Melanie P. Hoenig, MD
- Basic Concepts of Immunology in Autoimmune Kidney Disease –Â Ramon G. Bonegio, MD
- Question and Answer Session –Â Faculty
- Renal Pathology in 2021 – Part 1 Nephritic Conditions – Helmut G. Rennke, MD
- Renal Pathology in 2021 – Part 2 – Astrid Weins, MD, PhD
- Current Approaches to Urine Sediment Analysis –Â Martina M. McGrath, MB BCh
- Question and Answer Session –Â Faculty
- IgA Nephropathy –Â Gerald B. Appel, MD
- Membranous Nephropathy –Â Laurence H. Beck, Jr., MD, PhD
- ANCA Vasculitis –Â John L. Niles, MD
- Question and Answer Session –Â Faculty
- Update on Lupus Nephritis –Â Gerald B. Appel, MD
- Metabolic Management of Kidney Stones –Â Gary Curhan, MD, ScD
- Anemia Management: Update and Best Practices –Â Ajay K. Singh, MBBS, FRCP (UK), MBA
- Question and Answer Session –Â Faculty
- Hyponatremia and Hypernatremia – Sodium Disorders – David B. Mount, MD
- Hypokalemia and Hyperkalemia – Potassium Disorders – David B. Mount, MD
- Question and Answer Session –Â Faculty
- Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
- Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir
- Question and Answer Session –Â Faculty
- Treating Renal Patients with Rituximab in the Era of Covid-19 –Â David B. Mount, MD
- Genetics and Kidney Disease –Â Friedhelm Hildebrandt, MD
- Update on Polycystic Kidney Disease –Â Cristian Riella, MD
- Question and Answer Session –Â Faculty
- Pediatric Nephrology –Â Michael J.G. Somers, MD
- Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
- Health Disparities in Chronic Kidney Disease – Lupus Nephritis as a Model Social Determinants, Biology, and Unmet Needs –Â Winfred W. Williams, Jr., MD
- SPECIAL LECTURE — Pig-to-Human Xenotransplantation: NYU Langone Health’s Experience – Robert Montgomery, MD, PhD
- Why Do We Reject a Transplant? –Â Jamil R. Azzi, MD
- Transplant Immunosuppression for the Boards –Â Steven Gabardi, PharmD, BCPS, FAST, FCCP
- Question and Answer Session –Â Faculty
- Immunological Assessment Pre and Post Transplant –Â Melissa Y. Yeung, MD and Indira Guleria, PhD
- Early Post-Transplant Management –Â Anil K. Chandraker, MD
- Question and Answer Session –Â Faculty
- Evaluation of the Kidney Living Donor –Â Kassem Safa, MD
- Late Loss of the Kidney Transplant –Â Andrew S. Allegretti, MD, MSc
- Infections in Transplant Recipients –Â Sarah P. Hammond, MD
- Monitoring Kidney Transplant Patients: Beyond Creatinine –Â Saif Abdulkarim Muhsin, MB BCh
- Pre-Transplant Surgical Evaluation of Recipients –Â Jamil R. Azzi, MD
- Question and Answer Session –Â Faculty
- Poisonings and Intoxications: What a Nephrologist Needs to Know –Â Timothy B. Erickson, MD
- Late Post-Transplant Medical Complications –Â Leonardo V. Riella, MD, PhD
- Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) –Â Jean M. Francis, MD
- Geriatric Nephrology –Â Ernest I. Mandel, MD
- Pathophysiology and Treatment of Diabetic Kidney Disease –Â Gearoid M. McMahon, MB BCh
- Management of Hypertension after SPRINT – A Plethora of Guidelines – Richard J. Glassock, MD
- Question and Answer Session –Â Faculty
- Secondary Hypertension – Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
- Cardiorenal Syndrome –Â Finnian R. McCausland, MB BCh, MMSc, FRCPI
- Liver and the Kidney –Â Andrew S. Allegretti, MD, MSc
- Question and Answer Session –Â Faculty
- Pathophysiology of Acute Kidney Injury –Â Joseph V. Bonventre, MD, PhD
- Acute Kidney Injury Syndromes –Â Alice M. Sheridan, MD
- ICU Nephrology and Continuous Renal Replacement Therapies –Â David J.R. Steele, MB BCh
- Question and Answer Session –Â Faculty
- Cancer and Acute Kidney Injury –Â Albert Q. Lam, MD
- Paraprotein Induced Kidney Injury –Â Albert Q. Lam, MD
- Focal and Segmental Glomerulosclerosis (FSGS): A Lesion, Not a Disease –Â Richard J. Glassock, MD
- From Genes to Therapies –Â Anna Greka, MD, PhD
- APOL1 and Kidney Disease –Â Opeyemi Olabisi, MD, PhD
- Question and Answer Session –Â Faculty
- Dialysis Dosing –Â Kevin Tucker, MD
- Mineral and Bone Disease –Â David Bushinsky, MD
- Question and Answer Session –Â Faculty
- Dialysis – A Case-Based Clinical Review and Update – Kevin Tucker, MD
- Pearls in Mineral and Bone Disease –Â David Bushinsky, MD
- Chronic Kidney Disease Epidemiology – A 2022 Update – Gearoid M. McMahon, MB BCh
- Question and Answer Session –Â Faculty
- Peritoneal Dialysis –Â Joanne M. Bargman, MD, FRCPC
- Peritoneal Dialysis Complications –Â Joanne M. Bargman, MD, FRCPC
- Peritoneal Dialysis: Audience Questions Answered –Â Kevin Tucker, MD
- Acute Kidney Injury Related to Immune Checkpoint Inhibitors –Â Shruti Gupta, MD, MPH
- Mesoamerican Nephropathy –Â Ricardo Correa-Rotter, MD
- Renal Ultrasound for the Clinical Nephrologist –Â Adina S. Voiculescu, MD
- Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
- Question and Answer Session –Â Faculty
- Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
- Must-Know Clinical Images in Nephrology –Â Ajay K. Singh, MBBS, FRCP (UK), MBA
- Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir
- Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir
- Chronic Kidney Disease in the Community – Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP
- COVID-19 Vaccination Response in Transplant Patients –Â Ann E. Woolley, MD
- Update on Renovascular Disease –Â Joseph M. Garasic, MD
- Pre-Transplant Surgical Evaluation of Recipients –Â Sayeed Malek, MD, FACS
- Immunologic Basis of Kidney Disease –Â Vivek Kasinath, MD
- Use of Checkpoint Inhibitors in Kidney Transplant Recipients –Â Naoka Murakami, MD, PhD
- Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
- Ethics in Nephrology –Â Valerie Luyckx, MD, MB BCh
- Pregnancy and Renal Disease –Â Jessica Tangren, MD
- Transplant Cases: Board Review Practice –Â Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD
- Transplant Board Review –Â Anil K. Chandraker, MD
- Must-Know Board Zebras –Â Emily S. Robinson, MD, MPH
- Nephrology Board Review Practice 1 –Â Finnian McCausland, MB BCh, MSc, FRCPI
- Nephrology Board Review Practice 2 –Â Mallika Mendu, MD, MBA
See Also: Comprehensive nephrology updates Reviews (91 MP4 + 149 PDF files)
Reviews
There are no reviews yet.